Ziprasidone Augmentation in an Adolescent with Obsessive Compulsive Disorder: A Case Report.

Psychopharmacol Bull

Dr. Demirkaya, MD, Assistant Professor, Child and Adolescent Psychiatry, Adnan Menderes University Faculty of Medicine, Aydin, Turkey. Dr. Alyanak, MD, Professor, Child and Adolescent Psychiatry, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.

Published: March 2016

Obsessive compulsive disorder (OCD) is characterized by recurrent, unwanted thoughts (obsessions) and/or repetitive behaviors (compulsions). Although selective serotonin reuptake inhibitors are widely used to treat OCD, only half of the patients respond well. Several potentiation strategies including off-label use of antipsychotics (mostly risperidone, quetiapine) have been tried. Ziprasidone is an atypical antipsychotic with the best affinity ratio of 5 HT and 5HT receptors. There is a limited data on ziprasidone in pediatric groups. The case described in the following is an example for the augmentation with ziprasidone to treatment refractory OCD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044488PMC

Publication Analysis

Top Keywords

obsessive compulsive
8
compulsive disorder
8
ziprasidone
4
ziprasidone augmentation
4
augmentation adolescent
4
adolescent obsessive
4
disorder case
4
case report
4
report obsessive
4
disorder ocd
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!